Department of pharmacology, Faculty of Medicine, Sfax University, Sfax, Tunisia.
Department of Pneumoallergology, Hedi Chaker Hospital, University of Sfax, Sfax, Tunisia.
J Clin Lab Anal. 2022 May;36(5):e24345. doi: 10.1002/jcla.24345. Epub 2022 Mar 22.
This study aims to evaluate markers of oxidative stress in Tunisian asthmatic patients and investigate whether their markers are correlated with uncontrolled asthma. This prospective cohort study was conducted on 48 healthy subjects and 60 patients with asthma (34 patients with controlled asthma and 26 patients with uncontrolled asthma). The levels of malondialdehyde (MDA), advanced oxidation protein products (AOPP), and glutathione (GSH), as well as the activities of glutathione peroxidase (GPx) and superoxide dismutase (SOD), were estimated in plasma by spectrophotometry. Asthmatic patients have significantly higher plasmatic levels of MDA and AOPP than healthy controls (p < 0.001). Lower GSH level and GPx activity were found in patients with asthma compared to controls (p < 0.001). In contrast, higher SOD activity was noted in asthmatic patients (p < 0.001). The comparison among the patients with controlled asthma and uncontrolled asthma revealed increased MDA and AOPP levels and SOD activity (p < 0.001) as well as a decreased GSH level and GPx activity (p = 0.004, p = 0.019) in patients with uncontrolled asthma. Spirometry level was significantly correlated with SOD activity (r = 0.447; p = 0.010), whereas no significant correlations were found with the other parameters (MDA, AOPP, GSH, and GPx). Asthmatic patients, especially those with uncontrolled asthma, suffer a high degree of reactive oxygen species (ROS) formation causing considerable oxidative stress. Increased MDA level and SOD activity and reduced GPx activity were predictors of poorly controlled asthma.
本研究旨在评估突尼斯哮喘患者的氧化应激标志物,并探讨其标志物是否与未控制的哮喘有关。这是一项前瞻性队列研究,共纳入 48 名健康受试者和 60 名哮喘患者(34 名哮喘控制患者和 26 名未控制哮喘患者)。采用分光光度法检测血浆中丙二醛(MDA)、晚期氧化蛋白产物(AOPP)、谷胱甘肽(GSH)水平以及谷胱甘肽过氧化物酶(GPx)和超氧化物歧化酶(SOD)活性。与健康对照组相比,哮喘患者的血浆 MDA 和 AOPP 水平显著升高(p<0.001)。与对照组相比,哮喘患者的 GSH 水平和 GPx 活性较低(p<0.001),而 SOD 活性较高(p<0.001)。控制组和未控制组哮喘患者比较显示,未控制组的 MDA 和 AOPP 水平以及 SOD 活性增加(p<0.001),GSH 水平和 GPx 活性降低(p=0.004,p=0.019)。肺功能水平与 SOD 活性显著相关(r=0.447;p=0.010),而与其他参数(MDA、AOPP、GSH 和 GPx)无显著相关性。哮喘患者,尤其是未控制组,存在高水平的活性氧(ROS)形成,导致明显的氧化应激。MDA 水平升高、SOD 活性增加和 GPx 活性降低是哮喘控制不良的预测因素。
J Clin Lab Anal. 2022-5
Pediatr Pulmonol. 2024-11
Inflammopharmacology. 2025-8-18
Naunyn Schmiedebergs Arch Pharmacol. 2025-4-17
Allergy Asthma Clin Immunol. 2020-7-22
Int J Mol Sci. 2020-6-18
Clin Exp Allergy. 2019-6
Open Access Maced J Med Sci. 2017-8-10